๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Anti-EGFR therapy in head and neck cancer: A surgeon's perspective

โœ Scribed by Colin Liew; C. Lemon

Book ID
116316480
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
54 KB
Volume
45
Category
Article
ISSN
0266-4356

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Perspectives of combined radioimmunother
Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer
โœ Frank B. van Gog; Ruud H. Brakenhoff; Marijke Stigter-van Walsum; Gordon B. Snow ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 119 KB ๐Ÿ‘ 2 views

Rhenium-186 based radioimmunotherapy (RIT) may have potential for the treatment of minimal residual disease in patients with squamous cell carcinoma of head and neck (HNSCC). In an effort to enhance the efficacy of RIT, we evaluated the combination of RIT and anti-epidermal growth factor receptor (E

TGF-ฮฑ and EGFR in head and neck cancer
TGF-ฮฑ and EGFR in head and neck cancer
โœ Jennifer R. Grandis; David J. Tweardy ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 340 KB

The upper aerodigestive tract mucosa of patients who develop squamous cell carcinoma of the head and neck (SCCHN) is predisposed to abnormally regulated growth, evidenced by the high incidence of synchronous and metachronous malignancies. We conducted a series of experiments to show that aberrant re